Skip to main content
NCBI home page
The Western Journal of Medicine logoLink to The Western Journal of Medicine
. 1996 Oct;165(4):234–240.

Parkinson's disease. Diagnosis and treatment.

D C Ng 1
PMCID: PMC1303759  PMID: 8987437

Abstract

Although Parkinson's disease is primarily a neurologic disorder, primary care physicians should be knowledgeable about the disease and its treatment because most patients will see their primary care physician first for their symptoms. Furthermore, in today's setting of managed care, primary care physicians will likely be called on even more to assume primary responsibility for the treatment of patients afflicted with Parkinson's disease; neurologists will likely play the role of consultants who see a patient only periodically and offer recommendations and advice for the primary care physicians to implement.

Full text

PDF
234

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahlskog J. E. Treatment of Parkinson's disease. From theory to practice. Postgrad Med. 1994 Apr;95(5):52-4, 57-8, 61-4 passim. [PubMed] [Google Scholar]
  2. Aminoff M. J. Treatment of Parkinson's disease. West J Med. 1994 Sep;161(3):303–308. [PMC free article] [PubMed] [Google Scholar]
  3. Bodagh I. Y., Robertson D. R. A risk-benefit assessment of drugs used in the management of Parkinson's disease. Drug Saf. 1994 Aug;11(2):94–103. doi: 10.2165/00002018-199411020-00004. [DOI] [PubMed] [Google Scholar]
  4. Brannan T., Yahr M. D. Comparative study of selegiline plus L-dopa-carbidopa versus L-dopa-carbidopa alone in the treatment of Parkinson's disease. Ann Neurol. 1995 Jan;37(1):95–98. doi: 10.1002/ana.410370117. [DOI] [PubMed] [Google Scholar]
  5. Calne D. B. Treatment of Parkinson's disease. N Engl J Med. 1993 Sep 30;329(14):1021–1027. doi: 10.1056/NEJM199309303291408. [DOI] [PubMed] [Google Scholar]
  6. Colcher A., Stern M. B. Therapy guided by symptoms for Parkinson's disease. Contemp Intern Med. 1995 Apr;7(4):39–47. [PubMed] [Google Scholar]
  7. Comella C. L., Stebbins G. T., Brown-Toms N., Goetz C. G. Physical therapy and Parkinson's disease: a controlled clinical trial. Neurology. 1994 Mar;44(3 Pt 1):376–378. doi: 10.1212/wnl.44.3_part_1.376. [DOI] [PubMed] [Google Scholar]
  8. Dogali M., Fazzini E., Kolodny E., Eidelberg D., Sterio D., Devinsky O., Berić A. Stereotactic ventral pallidotomy for Parkinson's disease. Neurology. 1995 Apr;45(4):753–761. doi: 10.1212/wnl.45.4.753. [DOI] [PubMed] [Google Scholar]
  9. Goetz C. G., Diederich N. J. Dopaminergic agonists in the treatment of Parkinson's disease. Neurol Clin. 1992 May;10(2):527–540. [PubMed] [Google Scholar]
  10. Hoehn M. M. The natural history of Parkinson's disease in the pre-levodopa and post-levodopa eras. Neurol Clin. 1992 May;10(2):331–339. [PubMed] [Google Scholar]
  11. Hughes A. J., Ben-Shlomo Y., Daniel S. E., Lees A. J. What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study. Neurology. 1992 Jun;42(6):1142–1146. doi: 10.1212/wnl.42.6.1142. [DOI] [PubMed] [Google Scholar]
  12. Iacono R. P., Shima F., Lonser R. R., Kuniyoshi S., Maeda G., Yamada S. The results, indications, and physiology of posteroventral pallidotomy for patients with Parkinson's disease. Neurosurgery. 1995 Jun;36(6):1118–1127. doi: 10.1227/00006123-199506000-00008. [DOI] [PubMed] [Google Scholar]
  13. Koller W. C., Pahwa R. Treating motor fluctuations with controlled-release levodopa preparations. Neurology. 1994 Jul;44(7 Suppl 6):S23–S28. [PubMed] [Google Scholar]
  14. Larsen J. P., Dupont E., Tandberg E. Clinical diagnosis of Parkinson's disease. Proposal of diagnostic subgroups classified at different levels of confidence. Acta Neurol Scand. 1994 Apr;89(4):242–251. doi: 10.1111/j.1600-0404.1994.tb01674.x. [DOI] [PubMed] [Google Scholar]
  15. Lozano A. M., Lang A. E., Galvez-Jimenez N., Miyasaki J., Duff J., Hutchinson W. D., Dostrovsky J. O. Effect of GPi pallidotomy on motor function in Parkinson's disease. Lancet. 1995 Nov 25;346(8987):1383–1387. doi: 10.1016/s0140-6736(95)92404-3. [DOI] [PubMed] [Google Scholar]
  16. Marttila R. J., Rinne U. K. Progression and survival in Parkinson's disease. Acta Neurol Scand Suppl. 1991;136:24–28. doi: 10.1111/j.1600-0404.1991.tb05016.x. [DOI] [PubMed] [Google Scholar]
  17. Olanow C. W., Hauser R. A., Gauger L., Malapira T., Koller W., Hubble J., Bushenbark K., Lilienfeld D., Esterlitz J. The effect of deprenyl and levodopa on the progression of Parkinson's disease. Ann Neurol. 1995 Nov;38(5):771–777. doi: 10.1002/ana.410380512. [DOI] [PubMed] [Google Scholar]
  18. Paulson G. W. Management of the patient with newly-diagnosed Parkinson's disease. Geriatrics. 1993 Feb;48(2):30-4, 39-40. [PubMed] [Google Scholar]
  19. Rubino F. A. Gait disorders in the elderly. Distinguishing between normal and dysfunctional gaits. Postgrad Med. 1993 May 1;93(6):185–190. doi: 10.1080/00325481.1993.11701693. [DOI] [PubMed] [Google Scholar]
  20. Stacy M., Jankovic J. Differential diagnosis of Parkinson's disease and the parkinsonism plus syndromes. Neurol Clin. 1992 May;10(2):341–359. [PubMed] [Google Scholar]
  21. Tanner C. M. Epidemiology of Parkinson's disease. Neurol Clin. 1992 May;10(2):317–329. doi: 10.1016/S0733-8619(18)30212-3. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Western Journal of Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES